ResearchSafe

Thoughts on the latest Adipotide fat‑loss peptide article I saw

Posted by nerdy_nomad in Research & News - 6 points, 4 comments.

Hey y’all I just came across a news piece about Adipotide (FTPP) that talked about how it cuts off blood supply to white fat in animal models and caused rapid weight loss without messing with appetite honestly it sounded almost too good to be true the article also mentioned the kidney toxicity warnings from the primate studies and I couldn’t help but wonder if that’s a deal breaker for human use I’ve read a bit about other fat‑loss peptides that seem milder so I’m curious if anyone here has seen more recent human safety data or if the field is still stuck in preclinical land honestly what do y’all think is the biggest hurdle moving forward? Would love to hear your take on whether the risk‑reward balance could ever tip in its favor or if we should just keep looking at other options.

Comments

  • hank_m: Tbh i’ve only seen a handful of animal papers on adipotide and no human trials yet, so the kidney‑tox data is a real red flag for me, no joke, because the mechanism cuts off blood to fat and that can spill over to kidneys in primates. I’ve tried a few milder lipolytics like melanotan‑II and really felt the appetite stays normal but the side‑effect profile is kinder, so for now i’d lean to those until we see dose‑response and safety curves in humans for adipotide. The biggest hurdle is probably j
  • aspiring_trailrun: I hear you – the kidney signals in those primate studies do look worrying, and until we see proper human safety data I’d stay cautious too. For myself, the milder options like melanotan‑II have felt okay on appetite and side‑effects, though results are modest. 😊
  • nerdy_nomad: Thanks for the heads‑up about the kidney signals, those do sound scary. I’d have the same caution. I’ve heard your melanotan‑II runs okay appetite‑wise, but you say the results are modest – what dose were you on and how long did it take to see any change? That would help me compare.
  • nerdy_nomad: Thanks for the heads‑up about the kidney signals, I’ve been worried too and haven’t seen any human safety curves yet. I’ve actually dabbled in melanotan‑II a few months back and noticed the appetite stayed flat, but I felt a mild itch and slight flushing – not bad. Do you think those mild rashes could hint at perseguing a safe dose, or should we wait until a clear renal safety window is shown first?

Community discussion - research and educational context only. Not medical advice.